Evidence map›Paper›PMID 32830310›Full record

ArticleJournal of thrombosis and thrombolysis2021

Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis.

Giovanni Merlino, Carmelo Smeralda, Gian Luigi Gigli, Simone Lorenzut, Sara Pez, Andrea Surcinelli, Alessandro Marini, Mariarosaria Valente

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 6 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 6 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Giovanni Merlino *Stroke Unit, Department of Neuroscience, Udine University Hospital, Piazzale S. Maria della Misericordia 15, 33100, Udine, Italy. giovanni.merlino@asufc.sanita.fvg.it.ORCID http://orcid.org/0000-0002-6525-9529
Carmelo Smeralda *Clinical Neurology, Udine University Hospital, Udine, Italy.
Gian Luigi GigliClinical Neurology, Udine University Hospital, Udine, Italy.
Simone LorenzutStroke Unit, Department of Neuroscience, Udine University Hospital, Piazzale S. Maria della Misericordia 15, 33100, Udine, Italy.
Sara PezClinical Neurology, Udine University Hospital, Udine, Italy.
Andrea SurcinelliClinical Neurology, Udine University Hospital, Udine, Italy.
Alessandro MariniClinical Neurology, Udine University Hospital, Udine, Italy.
Mariarosaria ValenteClinical Neurology, Udine University Hospital, Udine, Italy.
University of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No study investigated the possible detrimental effect of stress hyperglycemia on patients affected acute ischemic stroke (AIS) undergoing intravenous thrombolysis (IVT). A new index, the glucose-to-glycated hemoglobin ratio (GAR), has been developed for assessing stress hyperglycemia. We retrospectively analyzed data from a prospectively collected database of consecutive patients admitted to the Udine University Hospital with AIS that were treated with IVT from January 2015 to December 2019. Four hundred and fourteen consecutive patients with AIS undergoing IVT entered the study. The patients were then stratified into four groups by quartiles of GAR (Q1-Q4). The higher GAR index was, the more severe stress hyperglycemia was considered. Prevalence of 3 months poor outcome (37.7% for Q1, 34% for Q2, 46.9% for Q3, and 66.7% for Q4, p for trend = 0.001), 3 months mortality (10.5% for Q1, 7.5% for Q2, 11.2% for Q3, and 27.1% for Q4, p for trend = 0.001), and symptomatic intracranial hemorrhage (0.9% for Q1, 0.9% for Q2, 5.1% for Q3, and 17.7% for Q4, p for trend = 0.001) was significant different among the four groups. AIS patients with severe stress hyperglycemia had a significantly increased risk of 3 months poor outcome (OR 2.43, 95% CI 1.14-5.22, p = 0.02), 3 months mortality (OR 2.38, 95% CI 1.01-5.60, p = 0.04), and symptomatic intracranial hemorrhage (OR 16.76, 95% CI 2.09-134.58, p = 0.008) after IVT. In conclusion, we demonstrated that stress hyperglycemia, as measured by the GAR index, is associated to worse outcome in AIS patients undergoing IVT.

Indexed as

HyperglycemiaIntracranial HemorrhagesIschemic StrokeThrombolytic TherapyAgedBlood GlucoseFemaleGlycated HemoglobinHumansItalyMaleMortalityOutcome Assessment, Health CarePredictive Value of TestsPrognosisRetrospective StudiesBlood GlucoseGlycated HemoglobinAcute ischemic strokeIntravenous thrombolysisOutcomeStress hyperglycemia

Identifiers

PMID32830310
OpenAlexW3081026800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.